摘要
目的:观察加味资生丸治疗脾肾阳虚型肝硬化腹水患者的临床疗效。方法:将70例肝硬化腹水患者随机分为对照组和治疗组各35例。两组均采用西医基础治疗方案,治疗组加用加味资生丸,每次6?g,每日3次,4周为1个疗程,治疗2个疗程。比较两组患者治疗前后血清白蛋白变化、白/球比值、中医证候积分、生活质量评分。结果:与治疗前比较,两组患者用药后血清白蛋白含量、白/球比值、中医证候积分、生活质量评分均有改善。与对照组比较,治疗组用药后患者血清白蛋白含量、白/球比值、中医证候积分、生活质量评分均改善明显,差异有统计学意义(P<0.05)。结论:加味资生丸治疗脾肾阳虚型肝硬化腹水疗效显著,值得临床推广应用。
Objective : To observe the clinical efficacy of Zisheng Pill in the treatment of spleen and kidney yang deficiency type cirrhosis ascites. Methods : 70 patients with spleen and kidney yang deficiency type cirrhosis ascites were randomly divided into the control group and the treatment group (n=35). Two groups both used western medicine foundation treatment, and the treatment group added Zisheng Pill, 6 grams for each time, 3 times a day, 4 weeks as a course, treating for 2 course. Two groups serum albumin change, white/ball ratio, TCM syndrome integral, quality of life scores were compared before and after treatment. Results : Compared with those before treatment, two groups patients serum albumin content, ratio of white/ball, the TCM syndrome integral and quality of life score were improved. Compared with control group, treatment group after medication, patients' serum albumin content, ratio of white/ ball, the TCM syndrome integral, quality of life scores were improved significantly, the difference was statistically significant ( P〈0.05 ). Conclusion : Zisheng Pill in the treatment of spleen and kidney yang deficiency type cirrhosis ascites has obvious therapeutic effect, and is worthy of clinical popularization and application.
出处
《辽宁中医药大学学报》
CAS
2014年第4期198-200,共3页
Journal of Liaoning University of Traditional Chinese Medicine